Clinical outcomes of intestinal transplant recipients receiving maintenance basiliximab, sublingual tacrolimus and prednisone: A case series

CONCLUSION: The combination of monthly basiliximab, sublingual tacrolimus, and prednisone is an effective novel maintenance immunosuppression in intestinal transplantation. A larger and more extended study duration would be necessary to thoroughly assess the safety and sustained benefits of the novel maintenance immunosuppression regimen.PMID:38480040 | DOI:10.1016/j.humimm.2024.110787

Source: Human Immunology - March 13, 2024 Category: Allergy & Immunology Authors: Pierpaolo Di Cocco Alessandro Martinino Giulia Bencini Rachel Christensen Benito Valdepenas Egor Petrochenkov Stepan Akshelyan Jorge Almario-Alvarez Mario Spaggiari Ivo Tzvetanov Enrico Benedetti Source Type: research